Literature DB >> 3806749

Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.

J M Costa, P D Marsden, E A Llanos-Cuentas, E M Netto, E M Carvalho, A Barral, A C Rosa, C C Cuba, A V Magalhães, A C Barreto.   

Abstract

Eight Bahian patients with cutaneous leishmaniasis who had 20 or more ulcerative lesions of short duration are described. Of five identifications of isolated parasites, four were Leishmania braziliensis braziliensis and one was L. mexicana amazonensis. All but one had positive Montenegro tests initially, and all did after treatment. All had circulating anti-leishmanial antibodies and five responded well to glucantime therapy suggesting a functioning immune response. This is quite different to the anergic hansenoid leishmaniasis seen with L. mexicana amazonensis infections in Brazil. Possible reasons for the occurrence of this type of leishmaniasis are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3806749

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  37 in total

1.  Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period.

Authors:  Lara Jirmanus; Marshall J Glesby; Luiz H Guimarães; Ednaldo Lago; Maria Elisa Rosa; Paulo R Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors:  Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-02       Impact factor: 2.184

5.  Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds.

Authors:  Virgínia M G Silva; Daniela F Larangeira; Pablo R S Oliveira; Romina B Sampaio; Paula Suzart; Jorge S Nihei; Márcia C A Teixeira; José O Mengel; Washington L C dos-Santos; Lain Pontes-de-Carvalho
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

6.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

7.  Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.

Authors:  Adriano Queiroz; Rosana Sousa; Claudia Heine; Manuela Cardoso; Luiz Henrique Guimarães; Paulo Roberto Lima Machado; Edgar M Carvalho; Lee W Riley; Mary E Wilson; Albert Schriefer
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.

Authors:  A Schriefer; A L F Schriefer; A Góes-Neto; L H Guimarães; L P Carvalho; R P Almeida; P R Machado; H A Lessa; A Ribeiro de Jesus; L W Riley; E M Carvalho
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; João Luís Reis-Cunha; Ronaldo Alves Pinto Nagem; Cláudia Martins Carneiro; Eduardo Antônio Ferraz Coelho; Lúcia Maria da Cunha Galvão; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

10.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.